InvestorsHub Logo
icon url

Poor Man -

11/20/22 10:13 PM

#536312 RE: CrashOverride #536305

This year as in December 2022?
icon url

ccie1024

11/20/22 11:58 PM

#536331 RE: CrashOverride #536305

I suspect the threat of such a suit, both publicly and perhaps privately to his employer, may have been enough to shut him up.
icon url

OncoJock

11/21/22 7:47 AM

#536430 RE: CrashOverride #536305

Realistically, given the slow pace of recent events and the limitations on management's time and attention and staff and the reality of regulators who have many other fish to fry besides NWBO, I think the most we can expect before the end of the year is an announcement that commercial approval has been granted to Advent for manufacture of cell and gene therapy products in Sawston.

That, and the annual shareholders meeting.

Pretty sure the rest will have to wait until next year.

But share price may continue to accelerate as large mainstream press outlets around the world (New York, LA, Tokyo, Berlin, Montreal, etc.) pile on and follow the medical breakthrough story.